Literature DB >> 18376240

Update on progressive familial intrahepatic cholestasis.

Feras T Alissa1, Ronald Jaffe, Benjamin L Shneider.   

Abstract

Three distinct forms of familial intrahepatic cholestasis are the result of mutations in the ATP8B1, ABCB11, and ABCB4 genes. The pathophysiologies of the latter 2 of these diseases are well characterized and are the result of abnormalities in canalicular excretion of bile acids and phospholipids, respectively. The molecular pathophysiology of the systemic disease associated with mutations in ATP8B1 remains unclear. In all of these diseases, wide variations in clinical phenotypes have been observed. The variability can be ascribed at least in part to predicted genotype:phenotype correlations. Disease- and genotype-specific prognoses and therapeutic approaches may exist, although much more information needs to be ascertained before clinicians can confidently make decisions based on genetic information.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376240     DOI: 10.1097/MPG.0b013e3181596060

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  21 in total

1.  Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies.

Authors:  Kimberley Evason; Kevin E Bove; Milton J Finegold; A S Knisely; Sue Rhee; Philip Rosenthal; Alexander G Miethke; Saul J Karpen; Linda D Ferrell; Grace E Kim
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

2.  Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family.

Authors:  Yannick Beauséjour; Fernando Alvarez; Martin Beaulieu; Marc Bilodeau
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

Review 3.  Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.

Authors:  Ralf Kubitz; Carola Dröge; Stefanie Kluge; Claudia Stross; Nathalie Walter; Verena Keitel; Dieter Häussinger; Jan Stindt
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

4.  Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.

Authors:  Giovanni Vitale; Stefano Gitto; Francesco Raimondi; Alessandro Mattiaccio; Vilma Mantovani; Ranka Vukotic; Antonietta D'Errico; Marco Seri; Robert B Russell; Pietro Andreone
Journal:  J Gastroenterol       Date:  2017-12-13       Impact factor: 7.527

5.  Clinical and ABCB11 profiles in Korean infants with progressive familial intrahepatic cholestasis.

Authors:  Ji Sook Park; Jae Sung Ko; Jeong Kee Seo; Jin Soo Moon; Sung Sup Park
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

6.  Increased frequency of double and triple heterozygous gene variants in children with intrahepatic cholestasis.

Authors:  Monique L Goldschmidt; Reena Mourya; Jessica Connor; Phillip Dexheimer; Rebekah Karns; Alexander Miethke; Rachel Sheridan; Kejian Zhang; Jorge A Bezerra
Journal:  Hepatol Res       Date:  2015-07-14       Impact factor: 4.288

7.  Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1.

Authors:  Frank Chen; Ayantika Ghosh; Benjamin L Shneider
Journal:  J Lipid Res       Date:  2012-12-04       Impact factor: 5.922

8.  Novel ABCB11 mutations in a Thai infant with progressive familial intrahepatic cholestasis.

Authors:  Suporn Treepongkaruna; Amornphun Gaensan; Paneeya Pienvichit; Ondrej Luksan; A S Knisely; Pattana Sornmayura; Milan Jirsa
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 9.  Child with Jaundice and Pruritus: How to Evaluate?

Authors:  Barath Jagadisan; Anshu Srivastava
Journal:  Indian J Pediatr       Date:  2016-03-02       Impact factor: 1.967

10.  The 21st century hepatologist and a systems biology based approach to liver diseases.

Authors:  Lopa Mishra
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.